MorphoSys AG reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was EUR 95.76 million compared to EUR 41.24 million a year ago. Net loss was EUR 122.87 million compared to EUR 112.77 million a year ago. Basic loss per share from continuing operations was EUR 3.6 compared to EUR 3.3 a year ago. Diluted loss per share from continuing operations was EUR 3.6 compared to EUR 3.3 a year ago.
For the nine months, revenue was EUR 196.67 million compared to EUR 126.67 million a year ago. Net loss was EUR 480.51 million compared to EUR 133.49 million a year ago. Basic loss per share from continuing operations was EUR 14.07 compared to EUR 4.03 a year ago. Diluted loss per share from continuing operations was EUR 14.07 compared to EUR 4.03 a year ago.